[1]
X. Gómez, N. Valdez, and R. Paredes, “Tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: an unattended need”, Rev Peru Med Exp Salud Publica, vol. 34, no. 2, pp. 349–50, Jun. 2017, doi: 10.17843/rpmesp.2017.342.2690.